HOW MANY LIVES DOES A NEW MORE POTENT THROMBOLYTIC AGENT HAVE TO SAVE TO JUSTIFY ADDITIONAL INTRACRANIAL HEMORRHAGES
Publication
, Journal Article
HILLEGASS, WB; JOLLIS, JG; GRANGER, CB; CALIFF, RM; MARK, DB
Published in: CLINICAL RESEARCH
April 1, 1993
Duke Scholars
Published In
CLINICAL RESEARCH
ISSN
0009-9279
Publication Date
April 1, 1993
Volume
41
Issue
2
Start / End Page
A122 / A122
Publisher
SLACK INC
Citation
APA
Chicago
ICMJE
MLA
NLM
HILLEGASS, W. B., JOLLIS, J. G., GRANGER, C. B., CALIFF, R. M., & MARK, D. B. (1993). HOW MANY LIVES DOES A NEW MORE POTENT THROMBOLYTIC AGENT HAVE TO SAVE TO JUSTIFY ADDITIONAL INTRACRANIAL HEMORRHAGES. CLINICAL RESEARCH, 41(2), A122–A122.
HILLEGASS, W. B., J. G. JOLLIS, C. B. GRANGER, R. M. CALIFF, and D. B. MARK. “HOW MANY LIVES DOES A NEW MORE POTENT THROMBOLYTIC AGENT HAVE TO SAVE TO JUSTIFY ADDITIONAL INTRACRANIAL HEMORRHAGES.” CLINICAL RESEARCH 41, no. 2 (April 1, 1993): A122–A122.
HILLEGASS WB, JOLLIS JG, GRANGER CB, CALIFF RM, MARK DB. HOW MANY LIVES DOES A NEW MORE POTENT THROMBOLYTIC AGENT HAVE TO SAVE TO JUSTIFY ADDITIONAL INTRACRANIAL HEMORRHAGES. CLINICAL RESEARCH. 1993 Apr 1;41(2):A122–A122.
HILLEGASS, W. B., et al. “HOW MANY LIVES DOES A NEW MORE POTENT THROMBOLYTIC AGENT HAVE TO SAVE TO JUSTIFY ADDITIONAL INTRACRANIAL HEMORRHAGES.” CLINICAL RESEARCH, vol. 41, no. 2, SLACK INC, Apr. 1993, pp. A122–A122.
HILLEGASS WB, JOLLIS JG, GRANGER CB, CALIFF RM, MARK DB. HOW MANY LIVES DOES A NEW MORE POTENT THROMBOLYTIC AGENT HAVE TO SAVE TO JUSTIFY ADDITIONAL INTRACRANIAL HEMORRHAGES. CLINICAL RESEARCH. SLACK INC; 1993 Apr 1;41(2):A122–A122.
Published In
CLINICAL RESEARCH
ISSN
0009-9279
Publication Date
April 1, 1993
Volume
41
Issue
2
Start / End Page
A122 / A122
Publisher
SLACK INC